TRAF3 Gene Encephalopathy Acute Infection-Induced Herpes-Specific Susceptibility to Type 5 Genetic Test
Test Name: TRAF3 Gene Encephalopathy Acute Infection-Induced Herpes-Specific Susceptibility to Type 5 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TRAF3 Gene Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility to, Type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRAF3 Gene Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility to, Type 5.
Test Details
The TRAF3 gene is associated with susceptibility to acute encephalopathy induced by herpes virus type 5 (HHV-5), also known as cytomegalovirus (CMV). This condition is characterized by inflammation of the brain and can result in seizures, coma, and death.
NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes simultaneously. This can provide a more comprehensive analysis of genetic variations that may be associated with a particular condition.
A genetic test for TRAF3 gene encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, type 5 would involve analyzing the TRAF3 gene for any variations or mutations that may increase an individual’s risk for developing acute encephalopathy induced by HHV-5. This test may be recommended for individuals with a family history of the condition or those who have had recurrent or severe infections with HHV-5.
It is important to note that genetic testing alone cannot diagnose or predict the development of a particular condition. It should be used in conjunction with other diagnostic tools and medical evaluation by a healthcare provider.
| Test Name | TRAF3 Gene Encephalopathy acute infection-induced herpes-specific susceptibility to type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TRAF3 Gene Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TRAF3 Gene Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, type 5 |
| Test Details |
The TRAF3 gene is associated with susceptibility to acute encephalopathy induced by herpes virus type 5 (HHV-5), also known as cytomegalovirus (CMV). This condition is characterized by inflammation of the brain and can result in seizures, coma, and death. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes simultaneously. This can provide a more comprehensive analysis of genetic variations that may be associated with a particular condition. A genetic test for TRAF3 gene encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, type 5 would involve analyzing the TRAF3 gene for any variations or mutations that may increase an individual’s risk for developing acute encephalopathy induced by HHV-5. This test may be recommended for individuals with a family history of the condition or those who have had recurrent or severe infections with HHV-5. It is important to note that genetic testing alone cannot diagnose or predict the development of a particular condition. It should be used in conjunction with other diagnostic tools and medical evaluation by a healthcare provider. |
